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Purpose: To evaluate the association between chronic heart failure (CHF) and optic nerve 
head alterations.
Methods: A cross-sectional study was performed. Heart failure patients with recent   echocardiograms 
were subjected to ophthalmologic examinations, including intraocular pressure measurement, optic 
nerve head, and retinal nerve fiber layer evaluation using stereophotography, Heidelberg retinal 
tomography, and standard automated perimetry. The ocular findings were correlated with the car-
diological evaluation, and compared with a control group without cardiopathy.
Results: A total of 30 patients with CHF and 30 individuals without cardiopathy were enrolled 
in this study. The mean (standard deviation [SD]) intraocular pressure was 12.3 (2.5) mmHg in 
the CHF group, and 14.7 (2.9) mmHg in the control group (P , 0.001). The mean (SD) arterial 
blood pressure was 86.9 (17.1) mmHg in the CHF group, and 103.6 (15.2) mmHg in the control 
group (P , 0.001). The mean (SD) ocular perfusion pressure was 45.6 (11.1) mmHg in the 
CHF group, and 54.4 (10.4) mmHg in the control group (P = 0.001). The mean (SD) rim area 
was 1.41 (0.3) mm2 in the CHF group, and 1.60 (0.26) mm2 in the control group (P = 0.003). 
The mean (SD) vertical cup/disc ratio was 0.51 (0.17) in the CHF group, and 0.41 (0.18) in the 
control group (P = 0.02). The Moorfields regression analysis was outside the normal limits in 
16 out of 58 (27.6%) eyes of the CHF subjects, and in 4 out of 60 (6.7%) eyes of the control 
subjects (P = 0.01). The frequency of glaucoma was 10% in the CHF group, whereas none of 
the control subjects met the criteria for the diagnosis of glaucoma (P = 0.24).
Conclusion: CHF is associated with lower ocular perfusion pressure, and glaucomatous optic 
nerve head changes.
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Introduction
Glaucoma is a progressive optic neuropathy presenting with a distinct appearance of 
the optic nerve head (ONH) and visual field loss, and is the leading cause of irreversible 
blindness worldwide.1 The pathophysiological basis of primary open-angle glaucoma 
(POAG) and the factors contributing to its progression are not fully understood. The 
elevation of intraocular pressure (IOP) is the most important risk factor, and IOP 
reduction is currently the only evidence-based treatment. However, some patients 
develop glaucomatous neuropathy without ocular hypertension.2 Thus, other factors 
may be involved in the development and progression of glaucoma. The vascular theory 
describing the mechanism of glaucoma considers optic neuropathy as secondary to 
insufficient blood perfusion, due to either increased IOP or other risk factors leading 
to a reduction in the ocular blood flow.3 Several studies have demonstrated that the 
reduction of ONH perfusion is associated with glaucoma.3
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A history of heart disease is already considered to be a 
risk factor for the development of glaucoma.4 However, the 
role of heart failure in the reduction of ocular blood flow, 
and its possible role in the development of glaucoma in these 
patients has not yet been established. Chronic heart failure 
(CHF) is a serious and common condition in which an abnor-
mality of cardiac function is responsible for the heart’s failure 
to pump blood at a rate corresponding to the requirements 
of the metabolizing tissues.5 A complex neurohormonal 
system attempts to compensate for heart failure to ensure 
suitable perfusion of the tissues.6 However, studies indicate 
that cerebral blood flow may be reduced in these patients.7,8 
A recent study with color Doppler imaging reported reduced 
blood flow velocities and an increased resistance index in 
the ophthalmic artery of CHF patients.9 The purpose of this 
study was to evaluate the association between CHF and 
ONH alterations.
Methods
A cross-sectional study was performed. Patients with CHF 
symptoms and left ventricle ejection fractions below 55% 
documented by echocardiography were recruited from the out-
patient cardiomyopathy and heart failure clinic of the Federal 
University of São Paulo, Brazil. Noncardiopathic volunteers 
were included as a control group. The study was approved by 
the Institutional Ethics Committee and followed the tenets of 
the Declaration of Helsinki. Informed consent was obtained 
from all subjects prior to the study, after full disclosure of the 
nature and possible consequences of the study.
CHF cases and control subjects under 18 years of age, 
patients with a prior history of significant ocular disease, 
ocular trauma or ocular surgery, spherical equivalent 
greater than ±4.0 D, chronic corticosteroid usage (topical or 
systemic), angle closure suspect, secondary glaucoma, dense 
media   opacities, retinal disease, heart transplantation, stroke or 
any other neurological diseases were not included in the study.
Systolic and diastolic blood pressure readings were 
obtained and used to calculate the mean arterial blood pres-
sure (MAP) according to the following formula: MAP = 2/3 * 
diastolic blood pressure + 1/3 * systolic blood pressure. The 
mean ocular perfusion pressure (OPP) was calculated using 
the following formula: OPP = 2/3 * MAP – IOP.10
The diagnoses of POAG were based on the following 
criteria:11 (a) a vertical cup/disc ratio (VCDR) of $0.7, 
asymmetry between the right and left VCDRs of $0.15 or 
a remaining neural rim #10% of the diameter of the ONH 
(in upper or lower quadrants), and a visual field defect con-
sistent with glaucoma; (b) VCDR of $0.85 in either eye or 
asymmetry between the right and left VCDRs of $0.3 if a 
reliable field test result could not be obtained. The visual field 
defect was defined as being consistent with glaucoma if either 
of the following criteria were present: a cluster of three or 
more points with a P , 5%, with at least one with a P , 1% 
in pattern standard deviation, or a glaucoma hemifield test 
(GHT) outside of normal limits.
Ophthalmologic evaluation
All participants underwent a standardized examination that 
included best-corrected visual acuity, slit-lamp biomicroscopy, 
gonioscopy, Goldmann applanation tonometry, fundus 
biomicroscopy with a 78D lens, standard automated perimetry 
(SITA 24-2, Humphrey Visual Field Analyzer II; Carl Zeiss 
  Meditec, Dublin, CA), color stereoscopic ONH photography, 
and confocal scanning laser ophthalmoscopy (Heidelberg reti-
nal tomography, version 3.0; Heidelberg Engineering, Dosen-
heim, Germany). IOP measurement was performed three times 
in each eye, and the mean value was considered for the analysis. 
Visual field reliability criteria included less than 33% fixation 
losses, false-positive results, and false-negative results. The 
IOP was measured before pupil dilation, and within 30 minutes 
of the arterial blood pressure measurement. All of the IOP 
measurements were performed between 8:00 am and 11:00 
am. After pupil dilation, the ONHs were imaged using HRT, 
a confocal scanning laser ophthalmoscope, which generates 
a mean topographic image and a stereometric analysis after 
three consecutive ONH scans. In this study, all of the images 
must have demonstrated a pixel standard deviation (SD) of 
,50 µm. In the case of poor centration (more than a quarter 
of the ONH outside the target circle), empty series, blink or 
loss of fixation, or insufficient imaging clarity and exposure, 
the scan was not saved on the hard disk. The   assessment of the 
ONH findings according to the color and thinning of the neural 
rim and the presence of a hemorrhage and retinal nerve fiber 
layer (RNFL) defects were based on the evaluation of stereo-
photographs by an experienced examiner (LASM) blinded to 
the patients’ clinical data.
Statistical analysis
The correlations between the ONH morphologic param-
eters, left ventricle ejection fraction and the blood pressure 
measurements were calculated using the Pearson’s correla-
tion test. The generalized estimating equation with robust 
standard error was used to take into account the correlation 
between both eyes of the same individual in the comparisons 
of the mean values between the groups. It was calculated that 
57 eyes in each group were needed, in order to have 80% 
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power to detect a 0.1 difference in the VCDR between the 
groups, considering an SD of 0.14, an intracluster correlation 
between both eyes of the same individual of 0.85, a design 
effect of 1.85, and a significance level of 0.05.
Results
The study population comprised 30 patients with different 
stages of CHF, and 30 controls (noncardiopathic individuals). 
The left eye was excluded for one patient in the CHF group 
due to corneal opacity. Table 1 summarizes the patients’ main 
characteristics. Age, sex, spherical correction, and ONH size 
were not significantly different between the two groups.
The comparative analyses of IOP, OPP, and blood 
pressure between the groups are described in Table 2. The 
IOP ranged from 7 mmHg to 18 mmHg in the CHF group, 
and from 10 mmHg to 20 mmHg in the control group. The 
frequency of eyes with a mean OPP of ,42 mmHg was 28 
Table 1 Demographic and systemic data of the chronic heart 
failure and control groups
Variable CHF group Control group
N 30 30
Age, mean (SD), years 54.8 (12.2) 54.9 (12)
Sex
  Male, N (%)
  Female, N (%)
19 (63.3)
11 (36.7)
15 (50)
15 (50)
Race
  White, N (%) 
  Black, N (%)
  Asian, N (%)
14 (46.7)
15 (50)
1 (3.3)
17 (56.7)
13 (43.3)
0.00
Laterality
  Right eye, N (%)
  Left eye, N (%)
30 (50.8)
29 (49.2)
30 (50)
30 (50)
Visual acuity, median 
(Q1 to Q3)
20/20 (20/25 
to 20/20)
20/20 (20/25  
to 20/20)
Spheric equivalent, 
mean (SD), D
0.54 (1.45) 0.19 (1.47)
Cardiopathy etiology
  Chagas, N (%)
  Ischemic, N (%)
  Idiopathic, N (%)
  Others, N (%)
10 (33.3)
10 (33.3)
5 (16.7)
5 (16.7)
NA
Left ventricle ejection 
fraction, median (Q1 to Q3)
0.35 (0.30  
to 0.42)
NA
NYhA functional class of heart failure
  I, N (%)
  II, N (%)
  III, N (%)
16 (53.3)
10 (33.3)
4 (13.3)
NA
Medications
  Diuretics, N (%)
  β-blockers, N (%)
  ACE inhibitors, N (%)
  Digoxin, N (%)
29 (96.7)
28 (93.3)
29 (96.7)
4 (13.3)
4 (12.5)
1 (3.3)
5 (16.7)
NA
Abbreviations: ACE, angiotensin-converting enzyme; ChF, chronic heart failure; 
NYhA, New York heart Association; SD, standard deviation; NA, not applicable.
Table  2  Intraocular  pressure,  blood  pressure,  and  ocular 
perfusion pressure measurements
Variable CHF group 
Mean (SD)
Control group 
Mean (SD)
P*
Intraocular pressure 
(mmhg)
12.3 (2.5) 14.7 (2.9) ,0.001
Systolic blood 
pressure (mmhg)
110.4 (24.1) 130.2 (18) ,0.001
Diastolic blood 
pressure (mmhg)
75.2 (14.5) 90.3 (14.4) ,0.001
Mean blood 
pressure (mmhg)
86.9 (17.1) 103.6 (15.2) ,0.001
Mean ocular perfusion 
pressure (mmhg)
45.6 (11.1) 54.4 (10.4) 0.001
Note: *P values calculated with generalized estimating equations.
Abbreviation: ChF, chronic heart failure.
out of 59 (47.5%) in the CHF group, and 4 out of 60 (6.7%) 
in the control group (P = 0.002).
Of the 59 eyes included in the CHF group, one eye was 
excluded from the analysis of the HRT structural evaluation 
due to a topographic SD . 50 µm, and three other eyes were 
excluded from the stereophotography ONH evaluation due to 
poor image quality. The ONH evaluation through stereopho-
tography is shown in Table 3. There was no significant differ-
ence between the two groups regarding the presence of rim 
thinning, parapapillary atrophy and RNFL defect. No subject 
presented with a hemorrhage of the ONH or disc pit.
The mean values for the stereometric measures of the 
ONH measured by HRT are shown in Table 4. The frequency 
of eyes with a VCDR . 0.7 was 8 out of 59 (13.6%) in the 
CHF group, and 1 out of 60 (1.7%) in the control group 
(P = 0.04).
The frequency of eyes that demonstrated Moorfields 
regression analyses outside normal limits was 16 out of 58 
Table 3 Optic nerve head evaluation through stereophotography
Variable CHF group Control group P
N 28 30 –
Vertical cup/disc  
ratio, Mean (SD)
0.49 (0.19) 0.42 (0.15) 0.06*
horizontal cup/disc 
ratio, Mean (SD)
0.47 (0.17) 0.42 (0.15) 0.19*
Rim pale (focal  
or difuse) (%)
7.2 3.4 0.61†
Notch of the  
neural rim (%)
10.7 0.00 0.11†
Disc pit (%) 0.00 0.00 –
Disc hemorrhage (%) 0.00 0.00 –
RNFL defect (%) 7.2 0.00 0.24†
Note: *P values calculated with generalized estimating equations; †P values calculated 
with Fisher’s exact test.
Abbreviations: ChF, chronic heart failure; SD, standard deviation; RNFL, retinal 
layer fiber layer.
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Table 4 Stereometric measurements of the optic nerve head 
evaluated by the hRT
Stereometric 
measure
CHF group 
Mean (SD)
Control group 
Mean (SD)
P*
N (eyes) 57 60
Disc area, mm2 2.04 (0.46) 2.04 (0.45) 0.90
Cup area, mm2 0.67 (0.50) 0.45 (0.38) 0.04
Rim area, mm2 1.41 (0.30) 1.60 (0.26) 0.003
Rim steepness –0.24 (0.62) –0.22 (0.53) 0.81
Cup/disc area ratio 0.30 (0.17) 0.20 (0.14) 0.004
Cup volume, mm3 0.18 (0.21) 0.09 (0.10) 0.01
Rim volume, mm3 0.36 (0.13) 0.46 (0.14) ,0.001
Mean cup  
depth, mm
0.25 (0.11) 0.19 (0.09) 0.02
Maximum cup 
depth, mm
0.65 (0.23) 0.53 (0.25) 0.04
height variation  
contour
0.39 (0.08) 0.42 (0.11) 0.07
Cup shape measure –0.17 (0.08) –0.18 (0.08) 0.75
Mean RNFL  
thickness, µm
0.23 (0.08) 0.26 (0.07) 0.06
RNFL cross sectional 
area, mm2
1.18 (0.41) 1.32 (0.39) 0.08
horizontal RNFL  
curvature
–0.004 (0.06) 0.02 (0.05) 0.09
Vertical RNFL 
curvature
–0.10 (0.07) –0.12 (0.06) 0.37
Linear cup/disc ratio 0.51 (0.17) 0.41 (0.18) 0.02
Topographic SD 19.40 (8.74) 21.20 (7.20) 0.29
Note: *P values calculated with generalized estimating equations.
Abbreviations: RNFL, retinal layer fiber layer; CHF, chronic heart failure.
1.00
0.80
0.60
0.40
0.20
0.00
20.00 30.004 0.00
Mean ocular  perfusion pressure,
mmHg
C
u
p
/
d
i
s
c
 
r
a
t
i
o
50.006 0.00 70.008 0.00
Figure  1  Scatterplot  demonstrating  the  association  between  the  mean  ocular 
perfusion  pressure  and  the  cup:disc  ratio.  The  solid  line  corresponds  to  the 
representation of the quadratic function.
Notes: R² = 0.091, P = 0.005.
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Figure  2  Scatterplot  demonstrating  the  association  between  the  left  ventricle 
volume and the neural rim area in patients with chronic heart failure.
Notes: r = −0.382; P = 0.01.
(27.6%) in the CHF group, and 4 out of 60 (6.7%) in the 
control group (P = 0.018).
The VCDR exhibited a nonlinear correlation with the 
mean OPP (R2 = 0.091; P = 0.005) (Figure 1). The rim 
area showed a negative linear correlation with the volume 
of the left ventricle among patients with CHF (r = −0.382; 
P = 0.004) (Figure 2). The tests for a correlation between 
ONH stereometric measurements and cardiologic parameters 
of patients with CHF are described in Table 5.
Three eyes from the CHF group and two eyes of the 
control group were excluded from the analysis of visual field 
testing due to the low reliability of the tests. Regarding the 
frequency of perimetric alterations, 14 out of 56 (25%) eyes 
in the CHF group and 3 out of 58 (5.2%) eyes in the control 
group demonstrated a GHT outside normal limits (P = 0.037). 
The mean deviation was −2.78 (2.89) dB in the CHF group, 
and −1.52 (1.08) dB in the control group (P = 0.008). The 
mean PSD was 2.35 (1.66) dB in the CHF group, and 1.91 
(0.61) dB in the control group (P = 0.128).
The frequency of glaucoma was 10% (three patients, four 
eyes) in the CHF group, whereas none of the control subjects 
met the criteria for the diagnosis of POAG (P = 0.24). None of 
the individuals who met the diagnostic criteria for glaucoma 
had a previous diagnosis of glaucoma, or were using ocular 
hypotensive eye drops. The mean IOP of the subgroup of 
patients with glaucoma was 12.6 (3.65) mmHg, while the 
mean of the rest of the CHF group was 12.4 (2.34) mmHg 
(P = 0.88). The mean OPP was 40.9 (4.09) mmHg in the 
subgroup with glaucoma, and was 46.3 (11.65) mmHg for 
the rest of the CHF group (P = 0.17). The mean left ventricle 
ejection fraction was 0.35 (0.05) in patients with glaucoma, 
and 0.34 (0.1) for the rest of the CHF group (P = 0.76).
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Discussion
The results of this study indicated an association between CHF 
and glaucomatous ONH alterations. Patients with CHF demon-
strated a higher cup/disc ratio and a smaller rim area, compared 
with those control subjects without heart disease. This type 
of alteration of the ONH corresponds to the signs classically 
observed in glaucomatous damage.12 The CHF group also had 
a higher frequency of results outside of normal limits in the 
Moorfields regression analysis. This test provides good sensitiv-
ity and specificity for the diagnosis of glaucoma.13 Patients with 
CHF also had a higher frequency of visual field alterations as 
GHT outside normal limits and a lower mean deviation.
A previous epidemiology study observed a 2.4% preva-
lence of POAG in the southern region of Brazil among subjects 
aged over 40 years.14 The results of the present study indicated 
a 10% frequency of POAG in patients with CHF, which is 
significantly greater than that described for the Brazilian 
population. Because patients with glaucoma and heart failure 
did not display ocular hypertension, vascular causes such 
as systemic hypotension and low ocular perfusion pressure 
might be involved in the pathogenesis of glaucoma in these 
patients.
In this study, several parameters of cardiac injury sever-
ity correlated with the ONH stereometric measures, ie, more 
advanced heart disease was associated with greater damage 
to the optic nerve. The reduction in cardiac output is associ-
ated with compensatory mechanisms that include peripheral 
vasoconstriction in an attempt to maintain satisfactory blood 
pressure and perfusion to the essential tissues such as the heart 
and brain.7 In patients with heart failure, the sympathetic and 
renin–angiotensin systems are activated as a neurohormonal 
response to maintain cardiac output and hemodynamic 
  balance.8 However,   excessive neurohormonal activity during 
CHF causes a reduction in quality of life, increased mortality,15 
and increased cerebral vascular resistance, which is often 
accompanied by symptoms,8 such as cognitive dysfunction, 
that are present in 35% to 50% of patients with CHF.7,15 
Cerebral hypoperfusion is considered to be the main cause of 
cognitive impairment in patients with heart failure.16 In the 
retrobulbar circulation, vasoconstriction may cause instability 
of blood flow in the ONH. Ischemia followed by reperfusion is 
a known cause of oxidative stress and cell death by apoptosis. 
According to this pathophysiology, patients with CHF could 
theoretically be exposed to hemodynamic changes in ocular 
microcirculation and have an increased risk for developing 
glaucoma.
Several studies have demonstrated an association between 
glaucoma and cardiovascular disease. Some studies suggest 
that ischemic heart disease is more prevalent among patients 
with POAG, particularly in normal tension glaucoma.17,18 An 
echocardiographic study observed a trend toward a higher 
prevalence of myocardial relaxation dysfunction in patients with 
glaucoma.19 In a series of 10 cases of normal tension glaucoma, 
it was reported that there was a well-defined history of clinical 
shock secondary to various causes, including intestinal bleed-
ing, cardiac arrest, and acute myocardial infarction.20 Some 
studies in glaucoma patients observed an increased prevalence 
of vascular diseases such as ischemic heart disease, migraines, 
and peripheral vascular disease21 and an increased cardiovas-
cular risk.22 No studies were found in the literature concerning 
the investigation of glaucomatous ONH alterations in patients 
with heart failure.
The pathogenesis of ONH alteration in these patients was 
probably related to a reduction in ocular perfusion second-
ary to heart failure. However, we cannot rule out a possible 
thromboembolic etiology for the changes of the optic nerve 
found in patients with CHF because cardiovascular disease is 
an important risk factor for thrombotic events. However, this 
Table 5 Correlation between the cardiovascular parameters and stereometric measurements of the optic nerve head in patients with 
chronic heart failure
Cadiovascular variable Rim area Cup area Cup/disc area ratio RNFL thickness
r P* r P* r P* r P*
NYhA functional class of heart failure 0.03 0.52 –0.08 0.66 –0.71 0.67 0.12 0.14
Left ventricle ejection fraction 0.18 0.29 –0.25 0.06 –0.26 0.15 0.25 0.01
Left ventricle shortening fraction 0.36 0.01 –0.36 0.01 –0.37 0.04 0.26 0.05
Left ventricle diastolic volume –0.38 0.01 0.08 0.77 0.20 0.34 –0.10 0.39
Left ventricle systolic diameter –0.47 0.005 0.20 0.34 0.32 0.13 –0.13 0.34
Left ventricle diastolic diameter –0.36 0.03 0.11 0.71 0.22 0.30 –0.02 0.84
Left ventricle mass index –0.34 0.08 0.25 0.07 0.34 0.02 0.05 0.71
Systolic blood pressure –0.16 0.23 –0.06 0.67 –0.04 0.80 0.05 0.60
Diastolic blood pressure –0.19 0.62 –0.13 0.30 –0.10 0.47 0.03 0.73
Notes: r = Pearson’s correlation coefficient. *P values calculated with generalized estimating equations.
Abbreviations: NYHA, New York Heart Association; RNFL, retinal nerve fiber layer.
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etiology is improbable because the patients did not report any 
history of sudden decreased vision. Moreover, fundoscopic 
signs of anterior ischemic optic neuropathy such as neural 
rim pallor were uncommon (two patients), and did not cor-
relate with the glaucoma diagnosis.
The CHF group demonstrated a lower mean IOP than 
the control group, and no patients with heart failure had an 
IOP $ 21 mmHg. This may be because patients with CHF 
had significantly lower blood pressure. A positive correlation 
between blood pressure and IOP has been well documented.23 
For each 10 mmHg rise in systolic and diastolic blood pres-
sure, there is an increase in IOP ranging from 0.20 mmHg to 
0.44 mmHg and 0.40 mmHg to 0.85 mmHg, respectively.23 
It has been speculated that blood pressure plays a role in 
maintaining the hydrostatic pressure necessary for the produc-
tion of aqueous humor by the ciliary body.24 Blood pressure 
may also influence the episcleral pressure, and thus modify 
the aqueous humor drainage.25 Some of the medications 
used to treat heart failure, such as angiotensin-converting 
enzyme inhibitors,26 angiotensin receptor antagonists,27 beta-
blockers,28 and digoxin,29 may also directly influence IOP by 
inhibiting aqueous humor production.
The mean OPP was approximately 15% lower in CHF 
patients compared with that of control patients. This differ-
ence was due to the lower blood pressure found in patients 
with CHF. Hypotension in these patients may be caused 
by heart failure, or by the excessive vasodilatory effect of 
medications used to treat the disease. There was a nonlinear 
correlation between the OPP and the VCDR. The patients 
with a lower ocular perfusion pressure had higher VCDRs. 
This finding is consistent with previous studies that indicate 
low OPP is a risk factor for glaucomatous optic neuropathy.30 
However, according to the correlation described in this study, 
patients with high values for the OPP also showed high 
VCDRs. A curve representing the relationship between OPP 
and the VCDR (Figure 1) is similar to that described for the 
relationship between OPP and the prevalence of glaucoma 
in Latinos.31 This increased prevalence of excavation and 
glaucoma associated with higher levels of ocular perfusion 
pressure is probably related to the systemic arterial hyperten-
sion in this population group.
This study, however, does present a few limitations, such as 
the cross-sectional design, which impairs the ability to determine 
with certainty whether the heart failure preceded the changes of 
the ONH, and whether the low OPP in patients with CHF would 
be a natural consequence of the pathogenesis of cardiovascular 
disease, or due to the use of medications. Regarding the sample, 
the evaluated patients with CHF may not be representative of all 
cases of this disease, especially because they were outpatients. 
The presence of heart disease of different etiologies, different 
stages, and different risks for ocular microvasculature   alterations 
may have attenuated the differences between the cases and 
controls. Our sample consisted of outpatients (mainly functional 
classes I and II). However, the occurrence of glaucomatous 
changes in patients with mild-to-moderate CHF, and thus a lon-
ger life expectancy suggests that these patients might suffer some 
impact on their quality of life. Despite the similarity between 
the cases and controls regarding age and sex, other potential 
confounders were not controlled, such as carotid atherosclerosis 
and the use of medications. As to the diagnostic ability of the 
Moorfields regression analysis, one major drawback is the great 
structural variability of the ONH in the normal population. Race 
is an important factor   associated with this variability.32 Although 
the latest version of HRT   contains data from normal individuals 
of white and black races,33 no data from Latinos were included 
in this version.
The presence of glaucoma in patients with heart failure 
may be related to low cerebral blood flow and may be a poor 
prognostic factor for heart disease. The prevalence of heart 
failure is increasing in western countries, and the evolution 
of treatment and increased survival in turn increases the 
likelihood that more patients with heart failure may suffer 
the impact of glaucoma on their quality of life.
The treatment of normal tension glaucoma is a major chal-
lenge for specialists, because the disease continues to progress 
in many patients despite a reduction in IOP.2 POAG manage-
ment in patients with heart failure is complicated by contrain-
dication to the use of beta blockers and potential intolerance to 
alpha2-agonists. Further studies are needed to identify which 
glaucoma medications demonstrate real efficacy and tolerabil-
ity at this end of the disease spectrum, in which the change to 
ocular blood flow seems to be involved in the pathogenesis of 
glaucoma to a greater extent than the IOP. Because glaucoma 
is a slowly progressive disease and low perfusion pressure is 
not commonly observed in the general population, advanced 
heart failure may serve as an excellent clinical model to test 
the relationship between a low level of blood perfusion to the 
ocular tissues and the incidence of glaucomatous damage.
Conclusion
CHF is associated with glaucomatous alterations of the 
ONH. The low cardiac output, the decreased systemic blood 
pressure, and the low OPP might be related to the vascular 
pathogenesis of the ONH alterations.
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